BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38452310)

  • 1. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
    Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
    JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
    Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
    Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
    Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
    JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
    Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
    Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.
    Biesecker BB; Lewis KL; Umstead KL; Johnston JJ; Turbitt E; Fishler KP; Patton JH; Miller IM; Heidlebaugh AR; Biesecker LG
    JAMA Intern Med; 2018 Mar; 178(3):338-346. PubMed ID: 29356820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
    Pozzar RA; Seven M
    J Genet Couns; 2024 Apr; 33(2):392-401. PubMed ID: 37328917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
    Swisher EM; Rayes N; Bowen D; Peterson CB; Norquist BM; Coffin T; Gavin K; Polinsky D; Crase J; Bakkum-Gamez JN; Blank SV; Munsell MF; Nebgen D; Fleming GF; Olopade OI; Law S; Zhou A; Levine DA; D'Andrea A; Lu KH
    JAMA Oncol; 2023 Nov; 9(11):1547-1555. PubMed ID: 37707822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S; Giri VN
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
    Bradbury AR; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS
    J Natl Cancer Inst; 2018 Sep; 110(9):985-993. PubMed ID: 29490071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
    J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
    Abusamra SM; Solorzano MA; Luke M; Quarles J; Jacobs MF; Das S; Kasputis A; Okoth LA; Patel M; Seymore M; Caram MEV; Dunn RL; Merajver SD; Stoffel EM; Reichert ZR; Morgan TM
    J Urol; 2022 Nov; 208(5):1007-1017. PubMed ID: 35930793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
    Greenberg S; Slager S; Neil BO; Cooney K; Maughan B; Stopa N; Venne V; Zickmund S; Colonna S
    Prostate; 2020 Apr; 80(5):441-450. PubMed ID: 32027768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
    BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
    Breen KE; Symecko H; Spielman K; Gebert R; Shah IH; Pundock S; Batson M; Narayan VK; Stadler ZK; Autio KA; Abida W; Danila DC; Scher HI; Morris MJ; Hamilton JG; Robson ME; Domchek SM; Carlo MI
    J Urol; 2023 May; 209(5):918-927. PubMed ID: 36974724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.
    Conley CC; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Burgos C; Ricker C; Kim J; Graves KD; Ashing KT; Quinn GP; Soliman H; Vadaparampil ST
    J Genet Couns; 2021 Apr; 30(2):394-405. PubMed ID: 32936981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a decision support intervention for reducing decisional conflict in patients with elevated serum prostate-specific antigen: A randomized controlled trial.
    Wang TJ; Chiu PP; Chen KK; Hung LP
    Eur J Oncol Nurs; 2021 Feb; 50():101865. PubMed ID: 33212360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.